Assessment of antibiotic prophylaxis post cardiac implantable electronic device implantation: a retrospective cohort

Sarah Aljohani1, Lama Alfehaid2,3,4, Meshary Almeshary3,4

  • 1Pharmaceutical Care Department, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia.

Insights

Postoperative prophylactic antibiotics for cardiac implantable electronic devices (CIEDs) showed no significant difference in infection rates. Further research is needed to confirm these findings for CIED infections.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Medical Device Technology

Background:

  • Cardiac implantable electronic devices (CIEDs) are crucial for managing arrhythmias and preventing sudden cardiac death.
  • CIED-related infections are an increasing concern.
  • The role of postoperative prophylactic antibiotics in preventing CIED infections remains debated.

Purpose of the Study:

  • To assess current practices of postoperative prophylactic antibiotic use in CIED recipients.
  • To determine the incidence of CIED infections in relation to postoperative antibiotic administration.

Main Methods:

  • A retrospective cohort study was conducted at King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • The study included 200 adult patients who underwent CIED implantation between 2017 and 2022.
  • Infection rates post-antibiotic prophylaxis were the primary outcome, analyzed using Stata 18.5.

Main Results:

  • The cohort (n=200) had a median age of 64 years, with common comorbidities including hypertension and diabetes.
  • All patients received pre-operative antibiotics; 95% received postoperative antibiotics.
  • A low rate of infection was observed (0.5% definite, 1.5% possible), with no infections in the small group (n=10) not receiving postoperative antibiotics. Exploratory analysis showed no difference in infection rates based on duration or single-agent vs. combination therapy.

Conclusions:

  • Current prophylactic antibiotic strategies (≤7 days or single agent) did not show a detectable difference in CIED infection rates.
  • Larger prospective studies, including a control group not receiving prophylactic antibiotics, are necessary to definitively compare infection rates.
Abstract

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...